SCHEMBL5437956

SCHEMBL5437956

CSc1nc2c(ncn2C)c(=O)n1-c1ccc(Cl)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.42
APOBEC3G Q9HC16 1/20 0.42
LMNA P02545 3/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
TSHR P16473 1/20 0.39
ALOX12 P18054 1/20 0.39
MAPK1 P28482 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ALDH1A1 P00352 2/20 0.38
CDK1 P06493 1/20 0.38
ALDH1A2 O94788 1/20 0.37
ALDH1A3 P47895 1/20 0.37
POLB P06746 1/20 0.37
GRM1 Q13255 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
TLR8 Q9NR97 1/20 0.36
XDH P47989 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1997653 0.84 CDK1 (0.41) CDK1POLBGRM1SMN1; SMN2XDH
SCHEMBL5429549 0.83 XDH (0.46) LMNAMEN1KMT2ATSHRALOX12
SCHEMBL5438917 0.83 MEN1 (0.47) ATMLMNAMEN1KMT2ATSHR
SCHEMBL5438632 0.83 MAOB (0.55) TSHRNPSR1ALDH1A1ALDH1A2ALDH1A3
SCHEMBL4097727 0.82 CNR1 (0.45) ATMAPOBEC3GLMNAMEN1KMT2A
SCHEMBL5431372 0.82 MAOA (0.43) ATMAPOBEC3GKMT2ATSHRNPSR1
SCHEMBL5434299 0.81 ALDH1A1 (0.52) LMNAMEN1KMT2ATSHRALDH1A1
SCHEMBL5429219 0.81 ALDH1A2 (0.40) KMT2ATSHRNPSR1ALDH1A2ALDH1A3
SCHEMBL5436112 0.80 KMT2A (0.50) MEN1KMT2ANPSR1ALDH1A2ALDH1A3
SCHEMBL5445254 0.80 MAOA (0.41) KMT2ATSHRNPSR1ALDH1A2ALDH1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070135454-A1 Bicyclic pyrimidin-4(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1-receptor(vr1) BAYLISS TRACY 2007-06-14 US claimed
US-20070135454-A1 Bicyclic pyrimidin-4(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1-receptor(vr1) BAYLISS TRACY 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135454-A1 Bicyclic pyrimidin-4(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1-receptor(vr1) TRPV1, TRPV2, TRPV4 ATM 4434/4885APOBEC3G 4637/4885LMNA 4257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.